Incyte (INCY) Share-based Compensation Growth (1y) (2011 - 2026)
Incyte (INCY) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | -88.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.59% |
| Sep 30, 2025 | -7.41% |
| Jun 30, 2025 | -41.39% |
| Mar 31, 2025 | 887.72% |
| Dec 31, 2024 | 1,032.64% |
| Jun 30, 2024 | 329.18% |
| Mar 31, 2024 | -88.43% |
| Dec 31, 2023 | -87.40% |
| Jun 30, 2023 | -203.45% |
| Mar 31, 2023 | 2,370.11% |
| Dec 31, 2022 | 1,334.76% |
| Sep 30, 2022 | -96.19% |
| Jun 30, 2022 | 3.79% |
| Mar 31, 2022 | -89.21% |
| Dec 31, 2021 | 86.38% |
| Sep 30, 2021 | 448.63% |
| Jun 30, 2021 | -3.24% |
| Mar 31, 2021 | 37.00% |
| Dec 31, 2020 | -12,028.01% |
| Sep 30, 2020 | -82.07% |